Lorcaserin, marketed under the brand name belviq is a weight-loss drug developed by arena pharmaceuticalsit reduces appetite by activating a type of serotonin receptor known as the 5-ht 2c receptor in a region of the brain called the hypothalamus, which is known to control appetite it was removed from the market in the united states in 2020 due to its increased risk of cancer. Belviq (lorcaserin). The fda asked the maker of weight-loss drug belviq (lorcaserin) to take it off the market after a clinical trial showed an association with an increased risk of cancer.
belviq (lorcaserin)
0 comments:
Post a Comment
Note: Only a member of this blog may post a comment.